Clinical Trial Update: Safety Study of CNT-01 in Patients With Idiopathic TGCV [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 safety study of CNT-01 in patients with idiopathic triglyceride deposit cardiomyovasculopathy (TGCV), conduc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Triglyceride Deposit Cardiomyovasculopathy

Drugs mentioned

• CNT-01

Snippet

Sponsor: Osaka University | Conditions: Idiopathic Triglyceride Deposit Cardiomyovasculopathy | Phase 1, Phase 2 | Status: COMPLETED